Association between hospital cardiac management and outcomes for acute myocardial infarction patients

Medical Care
Therese A StukelPing Li

Abstract

Randomized trials have shown that medical and interventional therapies improve outcomes for acute myocardial infarction (AMI) patients. The extent to which hospital quality improvement translates into better patient outcomes is unclear. To determine hospital cardiac management markers associated with improved outcomes. RESEARCH DESIGN, SUBJECTS: Population-based longitudinal cohort study of 98,115 adults hospitalized with first episode of AMI during 2000 to 2006 in 77 Ontario hospitals with >50 annual AMI admissions. Rates of 30-day and 1-year mortality, readmissions for AMI or death, and major cardiac events (readmissions for AMI, angina, heart failure, or death) within 6 months, according to index hospital cardiac management markers, including appropriate initial emergency department (ED) assessment (rate of high acuity triage) high-acuity and intensity of interventional (30-day cardiac catheterization rate) and medical (discharge statin prescribing rate) therapy. Thirty-day risk-adjusted mortality varied 2.3-fold (7.2%-16.9%) and major cardiac events rates varied 2-fold (18.2%-35.6%) across hospitals in 2006. Patients admitted to hospitals with the highest versus lowest rates of combined medical and interventional management...Continue Reading

References

Mar 27, 2001·Journal of the American College of Cardiology·J V TuK M McDonald
May 10, 2001·JAMA : the Journal of the American Medical Association·D A AlterJ V Tu
Jun 28, 2001·JAMA : the Journal of the American Medical Association·J V TuB T Chan
Nov 22, 2002·The New England Journal of Medicine·John Z AyanianPeter Gaccione
Mar 31, 2004·Journal of the American College of Surgeons·John D BirkmeyerNancy J O Birkmeyer
Apr 22, 2004·JAMA : the Journal of the American Medical Association·Dennis T KoDavid A Alter
Mar 17, 2005·JAMA : the Journal of the American Medical Association·Therese A StukelDavid E Wennberg
Jun 16, 2005·JAMA : the Journal of the American Medical Association·Shamir R MehtaSalim Yusuf
Jul 22, 2005·The New England Journal of Medicine·Ashish K JhaArnold M Epstein
Oct 4, 2005·Journal of the American College of Cardiology·Kim A EagleUNKNOWN American College of Cardiology Foundation (Bethesda, Maryland) Guidelines Applied in Practice Steering committee
Apr 28, 2006·JAMA : the Journal of the American Medical Association·Eric D PetersonE Magnus Ohman
Jul 6, 2006·JAMA : the Journal of the American Medical Association·Elizabeth H BradleyHarlan M Krumholz
Jul 6, 2006·JAMA : the Journal of the American Medical Association·Ashish K Jha
Nov 15, 2006·The New England Journal of Medicine·Elizabeth H BradleyHarlan M Krumholz
Jan 4, 2007·JAMA : the Journal of the American Medical Association·Michael PineJunius Gonzales
Jan 11, 2007·JAMA : the Journal of the American Medical Association·Jeppe N RasmussenDavid A Alter
May 3, 2007·JAMA : the Journal of the American Medical Association·Keith A A FoxUNKNOWN GRACE Investigators
Jun 8, 2007·The New England Journal of Medicine·Earl S FordSimon Capewell
Oct 22, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Peter C AustinDavid A Alter
Oct 22, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jack V TuUNKNOWN Canadian Cardiovascular Outcomes Research Team / Canadian Cardiovascular Society Acute Myocardial Infarction Quality Indicat
Jan 23, 2009·Annals of Emergency Medicine·Clare L AtzemaMichael J Schull
Apr 3, 2009·The New England Journal of Medicine·Stephen F JencksEric A Coleman

❮ Previous
Next ❯

Citations

Mar 15, 2012·JAMA : the Journal of the American Medical Association·Therese A StukelDouglas S Lee
May 31, 2011·Annales Françaises D'anesthèsie Et De Rèanimation·J JosseaumeJ Mantz
Jul 3, 2013·American Journal of Surgery·Russell B HawkinsKuoJen Tsao
Apr 20, 2011·Journal of Evaluation in Clinical Practice·Mathew Mercuri, Amiram Gafni
Aug 3, 2014·Applied Nursing Research : ANR·Mary L JohansenJeannie P Cimiotti
Nov 8, 2014·PloS One·Claudia FischerEwout W Steyerberg
Feb 26, 2016·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Michael PineBarbara A Dennison
Mar 10, 2012·Stroke; a Journal of Cerebral Circulation·Sònia AbilleiraMiquel Gallofré
Sep 14, 2018·The Journal of Cardiovascular Nursing·Pamela B de CordovaJeannette Rogowski
May 6, 2021·Journal of General Internal Medicine·John A StaplesJason M Sutherland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.